Skip to main content
European Clinical Respiratory Journal logoLink to European Clinical Respiratory Journal
. 2026 Sep 15;13(1):2728252. doi: 10.1080/20018525.2026.2728252

Correction

PMCID: PMC13580362  PMID: 42751257

Article title: Effects of long-term, home-based, virtual cycling after COPD exacerbation – results from the randomised controlled COPDtoParis trial

Authors: Anna L. Stoustrup, Lars P. Thomsen, Jane Andreasen, Thorvaldur S. Palsson, Anne Vingaard Olesen, Kristina K. Christensen, Dennis Grønhøj and Ulla M. Weinreich

Journal: European Clinical Respiratory Journal

Bibliometrics: Volume 13, Number 01, pages 1-15

DOI: https://doi.org/10.1080/20018525.2026.2673711

It has been noted by the authors that few values in Table 3 were incorrect in the published article. The corrected version of Table 3 has been placed below.

Table 3.

Outcomes at baseline and 12 months

Outcome
Group (n)
Baseline [95 % CI]
12 months [95 % CI]
Mean differences between groups
p-value
5 RSTS (seconds) Intervention (18) 18.3 [13.8;22.7] 11.8 [6.5;17.0] -1.1 [-8.1;6.0] 0.8
Control (19) 12.0 [7.6;16.5] 12.8 [8.1;17.5]
30s STS (repetitions) Intervention (21) 10.5 [0.1;20.9] 11.7 [-0.1;23.4] -3.5 [-18.2;11.2] 0.6
Control (19) 13.2 [-0.1;26.6] 15.2 [-0.2;30.6]
Sedentary time (hours) Intervention (21) 21.6 [20.5;22.7] 21.5 [19.5;23.4] 2.3 [-0.2;4.8] 0.08
Control (18) 19.2 [17.9;20.4] 19.2 [17.6;20.7]
Lung function, FEV1% pred. Intervention (19) 44.1 [38.7;49.6] 44.7 [38.5;50.9] 0.2 [-8.3;8.6] 0.9
Control (19) 46.3 [40.8;51.8] 44.6 [38.8;50.4]
SPPB, points Intervention (21) 5.1 [3.7;6.5] 5.3 [3.5;7.1] -1.3 [-3.8;1.1] 0.3
Control (19) 6.4 [4.9;7.8] 6.6 [5.0;8.3]
SGRQ, points Intervention (18) 54.9 [47.5;62.3] 49.2 [40.8;57.6] -3.2 [-14.6;8.2] 0.6
Control (19) 57.4 [50.1;64.8] 52.4 [44.6;60.1]
CAT, points Intervention (18) 11.3 [8.0;14.6] 10.6 [6.7;14.4] -4.7 [-9.9;0.5] 0.08
Control (19) 13.6 [10.4;16.9] 15.2 [11.7;18.7]
EQ-5D-5L, index score Intervention (18) 0.8 [0.6;0.9] 0.6 [0.5;0.8] -0.1 [-0.3;0.2] 0.6
Control (19) 0.7 [0.6;0.8] 0.7 [0.5;0.8]
EQ-VAS, 0-100 Intervention (18) 61.9 [51.8;72.1] 69.3 [57.0;81.7] 23.3 [6.7;39.9] 0.006
Control (18) 58.3 [48.2;68.5] 46.1 [35.0;57.1]
LSA-DK, points Intervention (18) 58.5 [45.4;71.6] 69.7 [54.9;84.6] 26.9 [6.6;47.2] 0.009
Control (19) 56.0 [43.3;68.8] 42.8 [29.0;56.6]

Abbreviations: Confidence interval (CI), 5RSTS, five-repetition sit-to-stand test; 30s STS, 30-second sit-to-stand test; FEV1% pred., forced expiratory volume in 1 second (% predicted); SPPB, Short Physical Performance Battery; SGRQ, St George’s Respiratory Questionnaire; CAT, COPD Assessment Test; EQ-5D-5L, EuroQol 5-Dimensions 5-Levels; EQ-VAS, EuroQol Visual Analogue Scale; LSA-DK, Life-Space Assessment, Danish version

In addition, in the Primary outcomes section, the sentence:

“Participants unable to perform the 5-repetition sit-to-stand test were assigned a score of 0.”

should read:

“Participants unable to perform the 5-repetition sit-to-stand test were treated as missing.”

This correction has not changed the description, interpretation, or the original conclusions of the article. The authors apologize for any inconvenience caused.

Updated table:


Articles from European Clinical Respiratory Journal are provided here courtesy of Taylor & Francis

RESOURCES